Retatrutide Weight Loss Drug: Future Outlook for 2026 | Retatrutide News

Retatrutide is a weight loss drug in Eli Lilly's pipeline, expected to impact GLP-1 research by 2026. AI is playing a role in the development of GLP-1 a...
Market News · October 10, 2026